Literature DB >> 16435565

The use of violacein to study biochemical behaviour of Saccharomyces cerevisiae cells.

Ricardo de Souza Pereira1, Nelson Durán, Pedro L O Volpe.   

Abstract

Violacein, a biochemical compound produced by Chromobacterium violaceum which has antichagasic properties, was used to study biochemical behaviour of Saccharomyces cerevisiae cells. At 20 microM and 40 microM, violacein did not alter the membrane potential (deltapsi) of S. cerevisae cells, which means that the integrity of the cell membrane was maintained. On the other hand, at 60 microM and 80 microM, violacein produced significant alterations in the membrane potential. This information will be very useful in using S. cerevisiae cells as a model to test the toxicity of new drugs before using in animals or human beings.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16435565     DOI: 10.1007/BF03190624

Source DB:  PubMed          Journal:  Eur J Drug Metab Pharmacokinet        ISSN: 0378-7966            Impact factor:   2.441


  10 in total

1.  Antileishmanial activity of the violacein extracted from Chromobacterium violaceum.

Authors:  L L Leon; C C Miranda; A O De Souza; N Durán
Journal:  J Antimicrob Chemother       Date:  2001-09       Impact factor: 5.790

2.  The use of calcium blockers to study biochemical behaviour of Saccharomyces cerevisiae cells.

Authors:  R de Souza Pereira
Journal:  Mol Cell Biochem       Date:  2001-12       Impact factor: 3.396

Review 3.  Recent developments in the identification of chemotherapeutics for Chagas disease.

Authors:  Jeffrey W Lockman; Andrew D Hamilton
Journal:  Curr Med Chem       Date:  2005       Impact factor: 4.530

Review 4.  The use of baker's yeast in the generation of asymmetric centers to produce chiral drugs and others compounds.

Authors:  R de S Pereira
Journal:  Crit Rev Biotechnol       Date:  1998       Impact factor: 8.429

5.  Violacein and its beta-cyclodextrin complexes induce apoptosis and differentiation in HL60 cells.

Authors:  Patrícia S Melo; Giselle Z Justo; Mariângela B M de Azevedo; Nelson Durán; Marcela Haun
Journal:  Toxicology       Date:  2003-04-22       Impact factor: 4.221

6.  Comparison of biochemical effects produced by calcium ions and by monomers of polyacrylamide (acrylamide and bisacrylamide) on strains of Saccharomyces cerevisiae used for production of chiral synthons.

Authors:  R de Souza Pereira
Journal:  Mol Cell Biochem       Date:  1998-01       Impact factor: 3.396

Review 7.  Integrating genetic approaches into the discovery of anticancer drugs.

Authors:  L H Hartwell; P Szankasi; C J Roberts; A W Murray; S H Friend
Journal:  Science       Date:  1997-11-07       Impact factor: 47.728

8.  Cytotoxicity and potential antiviral evaluation of violacein produced by Chromobacterium violaceum.

Authors:  C R Andrighetti-Fröhner; R V Antonio; T B Creczynski-Pasa; C R M Barardi; C M O Simões
Journal:  Mem Inst Oswaldo Cruz       Date:  2003-10-29       Impact factor: 2.743

9.  Bacterial chemistry. VI. Biological activities and cytotoxicity of 1,3-dihydro-2H-indol-2-one derivatives.

Authors:  M Haun; M F Pereira; M E Hoffmann; A Joyas; V Campos; L D Filardi; S L de Castro; N Duran
Journal:  Biol Res       Date:  1992       Impact factor: 5.612

10.  Baker's yeast. Some biochemical aspects and their influence in biotransformations.

Authors:  R de S Pereira
Journal:  Appl Biochem Biotechnol       Date:  1995-11       Impact factor: 2.926

  10 in total
  1 in total

1.  Versatile genetic assembly system (VEGAS) to assemble pathways for expression in S. cerevisiae.

Authors:  Leslie A Mitchell; James Chuang; Neta Agmon; Chachrit Khunsriraksakul; Nick A Phillips; Yizhi Cai; David M Truong; Ashan Veerakumar; Yuxuan Wang; María Mayorga; Paul Blomquist; Praneeth Sadda; Joshua Trueheart; Jef D Boeke
Journal:  Nucleic Acids Res       Date:  2015-05-08       Impact factor: 16.971

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.